Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.98
+0.14 (1.01%)
At close: Mar 9, 2026, 4:00 PM EDT
13.81
-0.17 (-1.22%)
After-hours: Mar 9, 2026, 7:10 PM EDT
Janux Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -113.63 | -68.99 | -58.29 | -63.06 | -32.67 | |
| Depreciation & Amortization | 2.03 | 2.06 | 1.96 | 0.84 | 0.11 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0 | |
| Loss (Gain) From Sale of Investments | -17.57 | -10.59 | -7.69 | -2.18 | -0.17 | |
| Stock-Based Compensation | 40.22 | 33.02 | 20.01 | 17.2 | 6.91 | |
| Change in Accounts Receivable | - | - | - | - | 8 | |
| Change in Accounts Payable | 0.98 | 1.58 | 0.28 | -0.29 | 2.14 | |
| Change in Unearned Revenue | - | -1.71 | -5.92 | 1.76 | -2.14 | |
| Change in Other Net Operating Assets | 5.74 | 0.81 | -0.91 | 2.81 | 0.84 | |
| Operating Cash Flow | -82.24 | -43.81 | -50.58 | -42.92 | -16.98 | |
| Capital Expenditures | -1.04 | -0.36 | -1.85 | -6.45 | -1.48 | |
| Investment in Securities | -299.94 | -257.66 | -39.34 | 64.71 | -339.48 | |
| Investing Cash Flow | -300.98 | -258.02 | -41.19 | 58.27 | -340.96 | |
| Issuance of Common Stock | 5.29 | 713.24 | 59.55 | 0.5 | 205.98 | |
| Other Financing Activities | -0.35 | - | - | - | -0.45 | |
| Financing Cash Flow | 4.95 | 713.24 | 59.55 | 0.5 | 386.52 | |
| Net Cash Flow | -378.27 | 411.4 | -32.22 | 15.84 | 28.59 | |
| Free Cash Flow | -83.28 | -44.17 | -52.43 | -49.37 | -18.46 | |
| Free Cash Flow Margin | -832.78% | -417.20% | -648.58% | -573.24% | -507.51% | |
| Free Cash Flow Per Share | -1.34 | -0.82 | -1.19 | -1.19 | -0.78 | |
| Levered Free Cash Flow | -51.27 | -26.14 | -29.52 | -30.56 | 0.58 | |
| Unlevered Free Cash Flow | -51.27 | -26.14 | -29.52 | -30.56 | 0.58 | |
| Change in Working Capital | 6.71 | 0.69 | -6.55 | 4.28 | 8.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.